Paula L. Jacobsen

1.6k citations

33 papers · 1.2k indexed · h-index 19

Pharmacology top 0.5%
Experimental and Cognitive Psychology top 2%
Psychiatry and Mental health top 5%
Biological Psychiatry top 1%
Cognitive Neuroscience top 10%

Co-authors: Atul R. Mahableshwarkar Yinzhong Chen Michael Serenko Michael E. Thase Madhukar H. Trivedi Anita H. Clayton George G. Nomikos Neven Henigsberg
Topics: Treatment of Major Depression (21 papers)Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (15 papers)Tryptophan and brain disorders (7 papers)
Cited by: Biological Psychiatry Pharmacology Experimental and Cognitive Psychology
Journals: JAMA Journal of Affective Disorders Psychopharmacology
Partner nations: United States Denmark France

In The Last Decade

Paula L. Jacobsen

30 papers receiving 1.1k citations

Peers

Countries citing papers authored by Paula L. Jacobsen

Since Specialization

Citations

This map shows the geographic impact of Paula L. Jacobsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paula L. Jacobsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paula L. Jacobsen more than expected).

Fields of papers citing papers by Paula L. Jacobsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paula L. Jacobsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paula L. Jacobsen. The network helps show where Paula L. Jacobsen may publish in the future.

Co-authorship network of co-authors of Paula L. Jacobsen

This figure shows the co-authorship network connecting the top 25 collaborators of Paula L. Jacobsen. A scholar is included among the top collaborators of Paula L. Jacobsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paula L. Jacobsen. Paula L. Jacobsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Vortioxetine 5, 10, and 20 mg significantly reduces the risk of relapse compared with placebo in patients with remitted major depressive disorder: The RESET study 2022 ·Journal of Affective Disorders ·Michael E. Thase,Paula L. Jacobsen,Elizabeth Hanson,(unknown),(unknown),Naga Venkatesha Murthy	9
2	A novel study design for investigating relapse prevention in major depressive disorder: Preliminary data from the open-label period of a phase 4 vortioxetine study 2020 ·Journal of Affective Disorders ·Paula L. Jacobsen,Wei Zhong,(unknown),George G. Nomikos	2
3	Clinical implications of directly switching antidepressants in well-treated depressed patients with treatment-emergent sexual dysfunction: a comparison between vortioxetine and escitalopram 2019 ·CNS Spectrums ·Paula L. Jacobsen,George G. Nomikos,Wei Zhong,Andrew J. Cutler,(unknown),Anita H. Clayton	27
4	Paroxetine, but not Vortioxetine, Impairs Sexual Functioning Compared With Placebo in Healthy Adults: A Randomized, Controlled Trial 2019 ·The Journal of Sexual Medicine ·Paula L. Jacobsen,Wei Zhong,George G. Nomikos,Anita H. Clayton	29
5	Suicidal ideation and behavior in adults with major depressive disorder treated with vortioxetine: post hoc pooled analyses of randomized, placebo-controlled, short-term and open-label, long-term extension trials 2019 ·CNS Spectrums ·Atul R. Mahableshwarkar,(unknown),Elin Heldbo Reines,(unknown),George G. Nomikos,Paula L. Jacobsen	9
6	Comparative evaluation of vortioxetine as a switch therapy in patients with major depressive disorder 2017 ·European Neuropsychopharmacology ·Michael E. Thase,Natalya Danchenko,Mélanie Brignone,Ioana Florea,(unknown),Paula L. Jacobsen,Eduard Vieta	21
7	A meta-analysis of the efficacy of vortioxetine in patients with major depressive disorder (MDD) and high levels of anxiety symptoms 2016 ·Journal of Affective Disorders ·David S. Baldwin,Ioana Florea,Paula L. Jacobsen,Wei Zhong,George G. Nomikos	74
8	A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Vortioxetine 10 mg and 20 mg in Adults With Major Depressive Disorder 2015 ·The Journal of Clinical Psychiatry ·Paula L. Jacobsen,Atul R. Mahableshwarkar,Michael Serenko,(unknown),Madhukar H. Trivedi	83
9	A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Vortioxetine in Adults With Major Depressive Disorder 2015 ·The Journal of Clinical Psychiatry ·Atul R. Mahableshwarkar,Paula L. Jacobsen,Michael Serenko,Yinzhong Chen,Madhukar H. Trivedi	72
10	A randomized, double-blind, duloxetine-referenced study comparing efficacy and tolerability of 2 fixed doses of vortioxetine in the acute treatment of adults with MDD 2015 ·Psychopharmacology ·Atul R. Mahableshwarkar,Paula L. Jacobsen,Yinzhong Chen,Michael Serenko,Madhukar H. Trivedi	84
11	Treatment-emergent sexual dysfunction in randomized trials of vortioxetine for major depressive disorder or generalized anxiety disorder: a pooled analysis 2015 ·CNS Spectrums ·Paula L. Jacobsen,Atul R. Mahableshwarkar,William Palo,Yinzhong Chen,Marianne Dragheim,Anita H. Clayton	43
12	Safety and tolerability of vortioxetine (15 and 20 mg) in patients with major depressive disorder 2015 ·International Clinical Psychopharmacology ·Paula L. Jacobsen,(unknown),Lambros Chrones,(unknown),Atul R. Mahableshwarkar	21
13	P.2.f.005 Vortioxetine effects on overall patient functioning in patients with major depressive disorder 2015 ·European Neuropsychopharmacology ·Ioana Florea,Henrik Loft,Natalya Danchenko,(unknown),(unknown),Elizabeth Merikle,David V. Sheehan,Paula L. Jacobsen	1
14	A randomized, double‐blind, fixed‐dose study comparing the efficacy and tolerability of vortioxetine 2.5 and 10 mg in acute treatment of adults with generalized anxiety disorder 2014 ·Human Psychopharmacology Clinical and Experimental ·Atul R. Mahableshwarkar,Paula L. Jacobsen,Michael Serenko,Yinzhong Chen	37
15	Safety, tolerability, and efficacy of vortioxetine (Lu AA21004) in major depressive disorder 2013 ·International Clinical Psychopharmacology ·(unknown),Paula L. Jacobsen,Yinzhong Chen,Michael Serenko,Atul R. Mahableshwarkar	57
16	A randomized, double-blind trial of 2.5 mg and 5 mg vortioxetine (Lu AA21004) versus placebo for 8 weeks in adults with major depressive disorder 2012 ·Current Medical Research and Opinion ·Atul R. Mahableshwarkar,Paula L. Jacobsen,Yinzhong Chen	109
17	A Randomized, Double-Blind, Placebo-Controlled 8-Week Trial of the Efficacy and Tolerability of Multiple Doses of Lu AA21004 in Adults With Major Depressive Disorder 2012 ·The Journal of Clinical Psychiatry ·Neven Henigsberg,Atul R. Mahableshwarkar,Paula L. Jacobsen,Yinzhong Chen,Michael E. Thase	129
18	Vortioxetine (Lu AA21004) in generalized anxiety disorder: Results of an 8-week, multinational, randomized, double-blind, placebo-controlled clinical trial 2012 ·European Neuropsychopharmacology ·Leszek Bidzan,Atul R. Mahableshwarkar,Paula L. Jacobsen,Mingjin Yan,David V. Sheehan	59
19	Vortioxetine (Lu AA21004) 5 mg in generalized anxiety disorder: Results of an 8-week randomized, double-blind, placebo-controlled clinical trial in the United States 2012 ·European Neuropsychopharmacology ·Anthony J. Rothschild,Atul R. Mahableshwarkar,Paula L. Jacobsen,Mingjin Yan,David V. Sheehan	47
20	Asperger syndrome and psychotherapy : understanding asperger perspectives 2003 ·TU Digital Collections (Thammasat University) ·Paula L. Jacobsen	4

About Paula L. Jacobsen

Paula L. Jacobsen is a scholar working on Biological Psychiatry, Experimental and Cognitive Psychology and Pharmacology, having authored 33 papers that have together received 1.2k indexed citations. Recurring topics across this work include Treatment of Major Depression (21 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (15 papers) and Tryptophan and brain disorders (7 papers). The work is most often cited by research in Biological Psychiatry (298 citations), Pharmacology (924 citations) and Experimental and Cognitive Psychology (559 citations). Paula L. Jacobsen has collaborated with scholars based in United States, Denmark and France. Frequent co-authors include Atul R. Mahableshwarkar, Yinzhong Chen, Michael Serenko, Michael E. Thase, Madhukar H. Trivedi, Anita H. Clayton, George G. Nomikos, Neven Henigsberg, Wei Zhong and David V. Sheehan. Their work appears in journals such as JAMA, Journal of Affective Disorders and Psychopharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact